Search Results - "Egleston, B.L"

Defining the Optimal Sequencing of Chemotherapy (Cx) and Radiation (RT) in Patients With Locally Advanced Pancreatic Cancer by Shaikh, T, Burki, M, Egleston, B.L, Wang, L, Cohen, S.J, Meyer, J.E

Get full text

Preclinical Testing Demonstrates Striking Efficacy of STA-12-8666, an Hsp90 Inhibitor–Targeted SN-38 Conjugate, in Small Cell Lung Cancer by Boumber, Y, Gaponova, A, Nikonova, A.S, Deneka, A, Kudinov, A, Chikwem, A, Egleston, B.L, Litwin, S, Duncan, J.S, Duncan, K, Borghaei, H, Mehra, R, Proia, D, Golemis, E

Get full text

Linked Dual Nomograms That Consider Radiation Dose and Length of Androgen Deprivation in the Estimation of Biochemical Failure at Five Years by Patel, V.N, Stoyanova, R, Guruju, R, Egleston, B.L, Pollack, A

Get full text

Symptom distress among older adults following cancer surgery by Van Cleave, J.H, Egleston, B.L, Ercolano, E, McCorkle, R

Get full text

Significant Increased Survival in Mesothelioma Patients Treated with Radiation and Surgery: An Analysis of the SEER Registry by Li, L, Lally, B, Egleston, B.L, Lebethal, A, Scott, W.J, Simon, G.R, Borghaei, H, Mehra, R, Kuritzky, N, Feigenberg, S.J

Get full text

Estimating Gains in Biochemical Outcome from Various Durations of Androgen Deprivation in Patients Treated with Dose Escalated Radiotherapy for Prostate Cancer using Two Nomograms by Pahlajani, N.H, Egleston, B.L, Buyyounouski, M.K, Chen, D.Y.T, Horwitz, E, Pollack, A

Get full text

Causes of death among cancer patients by Zaorsky, N.G., Churilla, T.M., Egleston, B.L., Fisher, S.G., Ridge, J.A., Horwitz, E.M., Meyer, J.E.

“…The purpose of our study was to characterize the causes of death among cancer patients as a function of objectives: (i) calendar year, (ii) patient age, and…”
Get full text

Causes of death among cancer patients as a function of calendar year, age, and time after diagnosis by Zaorsky, N.G., Churilla, T., Egleston, B.L., Fisher, S.G., Ridge, J.A., Horwitz, E.M., Meyer, J.E.

Get full text

The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial by Miller, S. M., Hudson, S. V., Egleston, B. L., Manne, S., Buzaglo, J. S., Devarajan, K., Fleisher, L., Millard, J., Solarino, N., Trinastic, J., Meropol, N. J.

“…Background Cancer clinical trials (CCTs) are important tools in the development of improved cancer therapies; yet, participation is low. Key psychosocial…”
Get full text

Preclinical Testing Demonstrates Striking Efficacy of STA-12-8666, an Hsp90 Inhibitor–Targeted SN-38 Conjugate, in Small Cell Lung Cancer: Small Cell Lung Cancer by Boumber, Y., Gaponova, A., Nikonova, A.S., Deneka, A., Kudinov, A., Chikwem, A., Egleston, B.L., Litwin, S., Duncan, J.S., Duncan, K., Borghaei, H., Mehra, R., Proia, D., Golemis, E.

Get full text

A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice by Little, J L, Serzhanova, V, Izumchenko, E, Egleston, B L, Parise, E, Klein-Szanto, A J, Loudon, G, Shubina, M, Seo, S, Kurokawa, M, Ochs, M F, Golemis, E A

“…Overexpression of the NEDD9/HEF1/Cas-L scaffolding protein is frequent, and drives invasion and metastasis in breast, head and neck, colorectal, melanoma, lung…”
Get full text